The genes associated with the development of cardiovascular diseases

Authors

  • S. A. Atambayeva Biology and biotechnology problems scientific-research institute of the al-Farabi Kazakh National University, Republic of Kazakhstan, Almaty
  • A. T. Ivashchenko Biology and biotechnology problems scientific-research institute of the al-Farabi Kazakh National University, Republic of Kazakhstan, Almaty
  • R. Y. Niyazova Biology and biotechnology problems scientific-research institute of the al-Farabi Kazakh National University, Republic of Kazakhstan, Almaty

Keywords:

atherosclerosis, hypertension, myocardial infarction, coronary heart disease, metabolic syndrome, gene, diagnosis.

Abstract

Сandidate genes associated with the development of cardiovascular diseases such as atherosclerosis, hypertension, myocardial infarction, coronary heart disease, metabolic syndrome are searched. A created database of the genes, associated with the development of these diseases have been analyzed in a comparative aspect.  It has been shown that some of the genes involved in the development of all the forms of cardiovascular disease (AGTR1, ALDH2, APOE, ICAM1, IGF1, LPL, MTHFR, PON1, SERPINE1, TGFB1, VEGFA). It was also shown that there are genes are involved in the development of only some one form of cardiovascular disease (ACSL1, ADTRP, AKT1, ALMS1, ANXA5, AQP2, AR, ATP2B1, CASZ1, CDH13, CELSR2, CFTR, CTSL, CUL7, DAP, DYRK1B, FIGN, FN1, FOS, FTO, GSN, HDAC9, ICOS, INPPL1, JAK2, LPIN1, MKKS, EDD4L, NFE2L2, PRL, SMTN, SOCS1, SOCS3, UMOD, WNT5A).  These results provide the basis for identifying genes, whose expression is dependent on the action of microRNA, since research on the identification of associations of these candidate genes like miRNA targets are of great importance because the low molecular weight RNA selectively regulate the expression of all human genes and may cause the disease, and used in the treatment, diagnostics of these diseases.

 

Cardiovascular disease - is the leading cause of death not only in Kazakhstan, but also throughout the world. Among the most common diseases, such as hypertension, metabolic syndrome, atherosclerosis, myocardial infarction, coronary heart disease. The problem of cardiovascular disease is one of the leading places among the major health problems of the XXI century, as it is one of the major causes of death, as well as temporary and permanent loss of working capacity of the population in the developed world.  Causes (etiology) occurrence of cardiovascular disease interconnected. Cardiovascular disease is multifactorial and arise under the influence of external and genetic factors. Currently, a huge amount of experimental work devoted to the search for  genetic factors (candidate genes), leading to the development of cardiovascular disease.  In the database NCBI (http://www.ncbi.nlm.nih.gov/) was searched gene, wherein the disease name as a keyword has been used. The audit was conducted by searching the relation of  this gene with the corresponding disease in publications over the past twenty years (http://www.ncbi.nlm.nih.gov/pubmed/). Thus, it appears link of gene with appropriate diseases, and created database of genes involved in the development of cardiovascular disease. Genes, associated with ischemic heart disease (174 genes), myocardial infarction (185 genes), atherosclerosis (213 genes),  hypertension (128 genes) and metabolic syndrome (182 genes) were found. A created database of the genes, associated with the development of these diseases have been analyzed in a comparative aspect.  It has been shown that some of the genes involved in the development of all the forms of cardiovascular disease (AGTR1, ALDH2, APOE, ICAM1, IGF1, LPL, MTHFR, PON1, SERPINE1, TGFB1, VEGFA). It was also shown that there are genes are involved in the development of only some one form of cardiovascular disease (ACSL1, ADTRP, AKT1, ALMS1, ANXA5, AQP2, AR, ATP2B1, CASZ1, CDH13, CELSR2, CFTR, CTSL, CUL7, DAP, DYRK1B, FIGN, FN1, FOS, FTO, GSN, HDAC9, ICOS, INPPL1, JAK2, LPIN1, MKKS, EDD4L, NFE2L2, PRL, SMTN, SOCS1, SOCS3, UMOD, WNT5A).  For example, revealed that more than 10 genes involved in the development of metabolic syndrome only. These results provide the basis for identifying genes, whose expression is dependent on the action of microRNA, since research on the identification of associations of these candidate genes like miRNA targets are of great importance because the low molecular weight RNA selectively regulate the expression of all human genes and may cause the disease, and used in the treatment, diagnostics of these diseases.

References

Литература

1 Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease // Journal of Clinical Endocrinology and Metabolism.– 2004.- 89(6). – Р.2595-600.
2 Erickson S.R., Spoutz P., Dorsch M., Bleske B. Cardiovascular risk and treatment for adults with intellectual or developmental disabilities // The International Journal of Cardiology.– 2016.- 5.221.– Р.371-375.
3 Tong D.C., Wilson A.M., Layland J. Novel risk factors for acute coronary syndromes and emerging therapies // The International Journal of Cardiology.-2016.- 25;220.- Р.815-824.
4 Ahmadi A., Stone G.W., Leipsic J., Shaw L.J., Villines T.C., Kern M.J., Hecht H., Erlinge D., Ben-Yehuda O., Maehara A., Arbustini E., Serruys P., Garcia-Garcia H.M., Narula J. Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease: Anatomy, Physiology, or Morphology? // Circulation Research, 2016.- 8.- 119(2).- Р.317-29.
5 Guha A., Amione-Guerra J., Park M.H. Epidemiology of Pulmonary Hypertension in Left Heart Disease // Progress in Cardiovascular Diseases.- 2016.- 8.- Р.30053-6.
6 Grinnan D., Farr G., Fox A., Sweeney L. The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial, Hypertension // Journal of Diabetes Research.- 2016.- Р.2481659.
7 Villa A.D., Sammut E., Nair A., Rajani R., Bonamini R., Chiribiri A. Coronary artery anomalies overview: The normal and the abnormal // World Journal of Radiology. 2016.- 28;8(6).- Р.537-55.
8 Trenkwalder T., Kessler T., Schunkert H., Erdmann J. Genetics of coronary artery disease: Short people at risk? // Expert Review of Cardiovascular Therapy.- 2015.- 13(11).- Р.1169-72.
9 Arbour L., Asuri S., Whittome B., Polanco F., Hegele R. The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations // Canadian Journal Of Cardiology.- 2015.- 31(9).- Р.1094-115.
10 Brænne I., Civelek M., Vilne B., Di. Narzo A, Johnson A.D., Zhao Y., Reiz B., Codoni V., Webb T.R., Foroughi Asl. H, Hamby S.E., Zeng L., Trégouët D.A., Hao K., Topol E.J., Schadt E.E., Yang X., Samani N.J., Björkegren J.L., Erdmann J., Schunkert H., Lusis A.J.; Leducq Consortium CAD Genomics Prediction of Causal Candidate Genes in Coronary Artery Disease Loci // Arteriosclerosis, Thrombosis, and Vascular Biology.- 2015.- 35(10).- Р.2207-17.
11 Hamrefors V. Common genetic risk factors for coronary artery disease: new opportunities for prevention? // Clinical Physiology And Functional Imaging.- 2015.- Р.17.
12 Cole C.B., Nikpay M., Stewart A.F., Mc.Pherson R. Increased genetic risk for obesity in premature coronary artery disease // European Journal of Human Genetics.- 2016.- 24(4).- Р.587-91.
13 Yamada Y., Matsui K., Takeuchi I., Fujimaki T. Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study study // Biomedical reports. – 2015.- 3(3).- P.413-419.
14 Ozaki K., Tanaka T. Molecular genetics of coronary artery disease // Journal of Human Genetics.- 2016.- 61(1).- р.71-7.
15 Neelankavil J., Rau C.D., Wang Y. The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets // Journal of Cardiothoracic and Vascular Anesthesia.- 2015.- 29(5).- Р.1328-32.
16 Hernesniemi J.A., Lyytikäinen L.P., Oksala N., Seppälä I., Kleber M.E., Mononen N., März W., Mikkelsson J., Pessi T., Louhelainen A.M., Martiskainen M., Nikus K., Klopp N., Waldenberger M., Illig T., Kähönen M., Laaksonen R., Karhunen P.J., Lehtimäki T. Predicting sudden cardiac death using common genetic risk variants for coronary artery disease // The European Heart Journal.- 2015.- 7;36(26).- Р.1669-75.
17 Cheng Y., An B., Jiang M., Xin Y., Xuan S. Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease // Hepatitis Monthly.- 2015.- 31.- 15(3).- P.26818.
18 Liao B., Cheng K., Dong S., Liu H., Xu Z. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease // Diagnostic Pathology.- 2015.- 16;10.- Р.102.
19 Arslan S., Korkmaz Ö., Özbilüm N., Berkan Ö. Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease // Biomedical reports.- 2015.- 3(5).- Р.736-740.
20 Ahmadi Z., Senemar S., Toosi S., Radmanesh S. The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City // Journal of Thoracic and Cardiovascular Surgery.- 2015.- 7(2).- Р.63-7.
21 Иващенко А.Т., Атамбаева Ш.А., Ниязова Р.Е., Пинский И.В. Гены, связанные с развитием ишемической болезни сердца // Вестник КазНУ, серия биологическая.- 2015.- №3 (65). - C. 100-108.
22 Иващенко А.Т., Атамбаева Ш.А., Ниязова Р.Е., Пинский И.В. Гены, связанные с развитием инфаркта миокарда // Вестник КазНУ, серия биологическая.- 2015.- №3 (65). – P. 124-132.

References

1 Grundy SM (2004) Obesity, metabolic syndrome, and cardiovascular disease, Journal of Clinical Endocrinology and Metabolism, 89(6):2595-600.
2 Erickson SR, Spoutz P, Dorsch M, Bleske B (2016) Cardiovascular risk and treatment for adults with intellectual or developmental disabilities, The International Journal of Cardiology, 5;221:371-375. DOI: 10.1016/j.ijcard.2016.07.044.
3 Tong DC, Wilson AM, Layland J (2016) Novel risk factors for acute coronary syndromes and emerging therapies, The International Journal of Cardiology, 25;220:815-824. DOI: 10.1016/j.ijcard.2016.06.148.
4 Ahmadi A, Stone GW, Leipsic J, Shaw LJ, Villines TC, Kern MJ, Hecht H, Erlinge D, Ben-Yehuda O, Maehara A, Arbustini E, Serruys P, Garcia-Garcia HM, Narula J (2016) Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease: Anatomy, Physiology, or Morphology? Circulation Research, 8;119(2):317-29. DOI: 10.1161/CIRCRESAHA.116.308952.
5 Guha A, Amione-Guerra J, Park MH (2016) Epidemiology of Pulmonary Hypertension in Left Heart Disease, Progress in Cardiovascular Diseases, 8. pii: S0033-0620(16)30053-6. DOI: 10.1016/j.pcad.2016.07.001.
6 Grinnan D, Farr G, Fox A, Sweeney L (2016) The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial, Hypertension, Journal of Diabetes Research, 2016:2481659. DOI: 10.1155/2016/2481659.
7 Villa AD, Sammut E, Nair A, Rajani R, Bonamini R, Chiribiri A (2016) Coronary artery anomalies overview: The normal and the abnormal, World Journal of Radiology, 28;8(6):537-55. DOI: 10.4329/wjr.v8.i6.537.
8 Trenkwalder T, Kessler T, Schunkert H, Erdmann J (2015) Genetics of coronary artery disease: Short people at risk? Expert Review of Cardiovascular Therapy, 13(11):1169-72. DOI: 10.1586/14779072.2015.1094377.
9 Arbour L, Asuri S, Whittome B, Polanco F, Hegele R (2015) The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations, Canadian Journal Of Cardiology, 31(9):1094-115. DOI: 10.1016/j.cjca.2015.07.005.
10 Brænne I, Civelek M, Vilne B, Di Narzo A, Johnson AD, Zhao Y, Reiz B, Codoni V, Webb TR, Foroughi Asl H, Hamby SE, Zeng L, Trégouët DA, Hao K, Topol EJ, Schadt EE, Yang X, Samani NJ, Björkegren JL, Erdmann J, Schunkert H, Lusis AJ; Leducq Consortium CAD Genomics (2015) Prediction of Causal Candidate Genes in Coronary Artery Disease Loci, Arteriosclerosis, Thrombosis, and Vascular Biology, 35(10):2207-17. DOI: 10.1161/ATVBAHA.115.306108.
11 Hamrefors V (2015) Common genetic risk factors for coronary artery disease: new opportunities for prevention? Clinical Physiology And Functional Imaging, 17. DOI: 10.1111/cpf.12289.
12 Cole CB, Nikpay M, Stewart AF, McPherson R (2016) Increased genetic risk for obesity in premature coronary artery disease, European Journal of Human Genetics, 24(4):587-91. DOI: 10.1038/ejhg.2015.162.
13 Yamada Y, Matsui K, Takeuchi I, Fujimaki T (2015) Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study study, Biomedical reports, 3(3), p.413-419.
14 Ozaki K, Tanaka T (2016) Molecular genetics of coronary artery disease, Journal of Human Genetics, 61(1):71-7. DOI: 10.1038/jhg.2015.70.
15 Neelankavil J, Rau CD, Wang Y (2015) The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets, Journal of Cardiothoracic and Vascular Anesthesia, 29(5):1328-32. DOI: 10.1053/j.jvca.2015.01.031. Epub 2015 Jan 23.
16 Hernesniemi JA, Lyytikäinen LP, Oksala N, Seppälä I, Kleber ME, Mononen N, März W, Mikkelsson J, Pessi T, Louhelainen AM, Martiskainen M, Nikus K, Klopp N, Waldenberger M, Illig T, Kähönen M, Laaksonen R, Karhunen PJ, Lehtimäki T (2015) Predicting sudden cardiac death using common genetic risk variants for coronary artery disease, The European Heart Journal, 7;36(26):1669-75. DOI: 10.1093/eurheartj/ehv106.
17 Cheng Y, An B, Jiang M, Xin Y, Xuan S (2015) Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease, Hepatitis Monthly, 31.15(3), p.26818.
18 Liao B, Cheng K, Dong S, Liu H, Xu Z (2015) Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease, Diagnostic Pathology, 16;10:102. DOI: 10.1186/s13000-015-0328-7.
19 Arslan S, Korkmaz Ö, Özbilüm N, Berkan Ö (2015) Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease, Biomedical reports, 3(5):736-740.
20 Ahmadi Z, Senemar S, Toosi S, Radmanesh S (2015) The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City, Journal of Thoracic and Cardiovascular Surgery, 7(2):63-7. DOI: 10.15171/jcvtr.2015.14.
21 Ivashchenko A, Atambayeva S, Niyazova R, Pinsky I (2015) Genes associated with the development of coronary heart disease. Vestnik KazNU, biological series [Geny svyazannye s razvitiem ishemicheskoi bolezni serdtca. Vestnik KazNU, biologicheskaya seriya] 3(65):100-108. (In Russian).
22 Ivashchenko A, Atambayeva S, Niyazova R, Pinsky I (2015) Genes associated with the development of myocardial infarction. Vestnik KazNU, biological series [Geny svyazannye s razvitiem infarcta miocarda. Vestnik KazNU, biologicheskaya seriya] 3(65): 124-132. (In Russian).

Downloads

Issue

Section

МOLECULAR BIOLOGY AND GENETICS

Most read articles by the same author(s)

1 2 3 > >>